Press Releases

Quotient Sciences and CytoAgents Accelerate Potential Treatment for COVID-19 Cytokine Storm

A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials was announced today by Quotient Sciences, a leading provider of innovative drug development and manufacturing solutions, and CytoAgents, Inc., a privately held biotechnology company focused on the development of pharmaceutical products for the treatment of viral infectious diseases.

Creative Diagnostics Launches SARS-CoV-2 Antigens and Antibodies for Research Use

Creative Diagnostics launches SARS-CoV-2 antigens and antibodies for global researchers.

PHARMASEAL expands Engility® Trial Management Platform with the addition of eTMF Document Storage

PHARMASEAL, an innovative provider of enterprise trial management solutions expands the capability of the Engility® clinical trial management platform. Electronic trial master file (eTMF) document storage is now available alongside Clinical Trial Management (CTMS) in the same integrated platform with enhanced productivity and operational benefits.

Chris O’Brien Lifehouse Hospital Ensures High Availability in the AWS Cloud with SIOS DataKeeper

AMRI Increases Hydroxychloroquine Sulfate API Production in U.S. to Meet Potential COVID-19 Demand

AMRI is increasing production of hydroxychloroquine sulfate API at its Rensselaer, N.Y., manufacturing facility to meet the rise in demand resulting from potential effectiveness of the product in treating COVID-19 symptoms.

The New Technology CAR-T Is Expected to Overcome AIDS After Being Transformed

HIV continues to be a major global public health issue, having claimed more than 32 million lives so far. However, the increasing access to effective HIV prevention, diagnosis and treatment has made it less threatening. Recently, convertibleCAR-T cell has been a hot issue for its great power to kill HIV-infected cells.

GlobalMed Offers Free Consultations to Healthcare Organizations Under Pressure to Implement Telehealth to Handle COVID-19 Surge

Provider community needs virtual technology, clinical guidance and proven telehealth implementation strategies to combat coronavirus. GlobalMed is offering a free consultative session for care providers, practices, and health systems interested in deploying telehealth.

Rho Experts Share Regulatory Best Practices on Product Development for the New Coronavirus

Free webinar offers insight into pathways to engage with Food and Drug Administration for COVID-19 product development

Ubiquitome targets testing travellers for COVID-19

Noxopharm Achieves Abscopal Responses in Prostate Cancer

Noxopharm is the first to achieve a meaningful abscopal responses in prostate cancer. Noxopharm reports a 27% incidence of abscopal response in soft tissue lesions using a combination of Veyonda® and low-dose radiotherapy.

Halfpenny Technologies, an Accumen Company, Launches COVID-19 Test Capacity and Routing Network Across 870 U.S. Hospitals to Accelerate Diagnostic Testing

This network uses a secure, cloud-based hub-and-spoke approach to process COVID-19 test orders and direct them efficiently to the nearest laboratory with capacity.

Norway’s arctic university Tromsø installs MR Solutions’ high field, dry magnet, PET-MR imaging system

Norway’s arctic university Tromsø installs MR Solutions’ high field, dry magnet, 7T PET-MR imaging system for preclinical research into inflammation, oncology and nephritis.

KCR’s Bryan Katz named in PM360’s ELITE 100

KCR, the international clinical development solutions provider, announced today that its Chief Commercial Officer, Bryan Katz, was honored by healthcare marketing industry trade magazine PM360 as one of their 2020 ELITE 100 award winners.

CluePoints Covid-19 Support Benefits Over 200 Clinical Studies Directly Affected by the Pandemic

CluePoints, the premier provider of Risk-Based Quality Management (RBQM) and Data Quality Oversight Software for clinical trials, today announced that its recently launched complimentary COVID-19 risk assessment package and Data Surveillance solution is being utilized in over 200 ongoing studies that are directly affected by Covid-19.

Lubrizol Contributes to Nike’s Efforts to Make Full-Face Shields for Frontline Medical Workers

BioIVT Introduces High-purity Kupffer Cells to Support Drug Discovery and Development for Liver Diseases and Help Predict Adverse Drug Reactions

Dysregulation of the Kupffer cell response contributes to liver diseases such as nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and liver fibrosis.

Rho Recognized with CRO Leadership Award from Leading Industry Publications

Rho Recognized with CRO Leadership Award from Leading Industry Publications Research Triangle Park, NC – May 11, 2020 – Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, has been honored with a 2020 CRO Leadership Award by leading industry publications Life Science Leader and Clinical Leader for the third time. The company was recognized in multiple categories, including Compatibility (Overall, Small Pharma); Expertise (Small Pharma); Quality (Overall, Small Pharma); and Reliability (Overall, Small Pharma). Selected by key decision makers in pharmaceutical and biopharmaceutical companies, award recipients are recognized as top CROs in the industry based on their recent achievements and ability to exceed customer expectations.

Two Top 25 Global Pharma Companies Adopt LifeSphere® Intake and Triage to Automate Adverse Event Case Processing

ArisGlobal Introduces LifeSphere CTMS10, Bringing Modern Simplicity and Efficiency to Clinical Trial Management

ArisGlobal, the leading provider of software that automates core drug development functions for over 300 life sciences companies, today announced the release of LifeSphere® CTMS10, a modern, end-to-end solution that makes the entire clinical trial management process easier and more transparent for companies of all sizes. Learn more...

India’s Largest Biopharmaceutical Selects LifeSphere® eTMF to Streamline Clinical Trial Document Management

ArisGlobal, the leading provider of life sciences software that automates drug development functions for over 300 life sciences companies, today announced that the largest biopharmaceutical company in India, a globally recognized organization enabling access to high quality, advanced therapies for chronic diseases, has selected ArisGlobal’s LifeSphere® eTMF as its electronic trial master file system.